Skip to main content
. Author manuscript; available in PMC: 2022 Jun 15.
Published in final edited form as: Stat Med. 2022 Feb 23;41(13):2303–2316. doi: 10.1002/sim.9356

Table 1.

Sample sizes n = nC = nT for the co-primary and multiple primary endpoints for overall power 1 − β ≈ 0.80, α = 0.025, km = 2, K = 4 using the MUSE trial data

SLEDAI PGA BILAG Taper
δ 1 σ12 δ 2 σ22 (πT3,πC3) σ3* (πT4,πC4) σ4* nco nmult SS 1 SS 2 SS 3 SS 4
0.88 18 0.38 0.35 (0.97,0.95) 0.24 (0.54,0.38) 0.40 403 46 365 39 273 99
0.88 19 0.38 0.35 (0.97,0.95) 0.24 (0.54,0.38) 0.40 419 46 386 39 273 99
0.88 20 0.38 0.35 (0.97,0.95) 0.24 (0.54,0.38) 0.40 435 46 406 39 273 99
0.88 18 0.38 0.45 (0.97,0.95) 0.24 (0.54,0.38) 0.40 403 55 365 49 273 99
0.88 18 0.38 0.55 (0.97,0.95) 0.24 (0.54,0.38) 0.40 403 63 365 60 273 99
0.88 18 0.38 0.65 (0.97,0.95) 0.24 (0.54,0.38) 0.40 403 70 365 71 273 99

Note: SS1, SS2, SS3, SS4 are sample sizes required per group for the individual endpoints for a power of at least 1 − β = 0.80.